SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion

[1]  M. Abe,et al.  ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.

[2]  B. Wasylyk,et al.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.

[3]  M. Abe,et al.  Ets‐1 regulates angiogenesis by inducing the expression of urokinase‐type plasminogen activator and matrix metalloproteinase‐1 and the migration of vascular endothelial cells , 1996, Journal of cellular physiology.

[4]  E. Yeh,et al.  Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.

[5]  Kevin J. Harrington,et al.  Encyclopedia of cancer, vols 1–3 , 1997 .

[6]  N. Bhat,et al.  Epitope mapping of human ETS1 monoclonal antibody. , 1994, Hybridoma.

[7]  A Farr,et al.  A pitfall of using a second plasmid to determine transfection efficiency. , 1992, Nucleic acids research.

[8]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[9]  T. Libermann,et al.  PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.

[10]  A. Lamond,et al.  Structure and function in the nucleus. , 1998, Science.

[11]  J. Ghysdael,et al.  The ETS Family of Transcriptional Regulators , 1997 .

[12]  V. Sementchenko,et al.  Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.

[13]  N. Bhat,et al.  A variant form of ETS1 induces apoptosis in human colon cancer cells , 1997, Oncogene.

[14]  J. Westermarck,et al.  Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors , 1997, Oncogene.

[15]  V. Sementchenko,et al.  Ets target genes: past, present and future , 2000, Oncogene.

[16]  B. Wasylyk,et al.  Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2 , 1997, Oncogene.

[17]  Runzhao Li,et al.  EAPII interacts with ETS1 and modulates its transcriptional function , 2003, Oncogene.

[18]  M. Cooper,et al.  An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons. , 2001, Immunity.

[19]  C. Hauser,et al.  Elevated Expression of Ets2 or Distinct Portions of Ets2 Can Reverse Ras-mediated Cellular Transformation* , 1998, The Journal of Biological Chemistry.

[20]  Runzhao Li,et al.  Regulation of Ets function by protein–protein interactions , 2000, Oncogene.

[21]  Roger Brent,et al.  C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .

[22]  R. Muise-Helmericks,et al.  Signal transduction and the Ets family of transcription factors , 2000, Oncogene.

[23]  Tien Hsu,et al.  Ets proteins in biological control and cancer , 2004, Journal of cellular biochemistry.

[24]  K. Howe,et al.  Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. , 1998, American journal of human genetics.

[25]  A. Dejean,et al.  Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Maul,et al.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. , 2000, Journal of structural biology.

[27]  A. Dejean,et al.  The PML nuclear bodies: actors or extras? , 1999, Current opinion in genetics & development.

[28]  B. Graves,et al.  Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.

[29]  Satoshi Obika,et al.  Sequence specific DNA binding of Ets-1 transcription factor: molecular dynamics study on the Ets domain--DNA complexes. , 2003, Journal of molecular biology.

[30]  C. Léger,et al.  Experimental bias in the evaluation of the cellular transient expression in DNA co-transfection experiments. , 1995, Cellular & molecular biology research.

[31]  G. Giannelli,et al.  Cancer Invasion: Watch Your Neighbourhood! , 2003, Tumori.

[32]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[33]  Jürgen Dittmer,et al.  The Biology of the Ets1 Proto-Oncogene , 2003, Molecular Cancer.

[34]  M. Ptashne,et al.  Chromatin components as part of a putative transcriptional repressing complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Klocker,et al.  Androgen Receptor-Ets Protein Interaction Is a Novel Mechanism for Steroid Hormone-mediated Down-modulation of Matrix Metalloproteinase Expression* , 1996, The Journal of Biological Chemistry.

[36]  L. Khachigian,et al.  Ets-1 Positively Regulates Fas Ligand Transcription via Cooperative Interactions with Sp1* , 2002, The Journal of Biological Chemistry.

[37]  Marc Aumercier,et al.  ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition* , 2002, The Journal of Biological Chemistry.

[38]  T. Sternsdorf,et al.  The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers* , 1999, The Journal of Biological Chemistry.

[39]  T. Sternsdorf,et al.  Nuclear dots: actors on many stages. , 1997, Immunobiology.

[40]  M. Duterque-Coquillaud,et al.  When Ets transcription factors meet their partners. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  B. Wiedenmann,et al.  Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. , 2003, Journal of the National Cancer Institute.

[42]  R. Li,et al.  The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  V. Sementchenko,et al.  ETS2 function is required to maintain the transformed state of human prostate cancer cells , 1998, Oncogene.

[44]  Runzhao Li,et al.  EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes , 2000, Oncogene.

[45]  A. Bassuk,et al.  A direct physical association between ETS and AP-1 transcription factors in normal human T cells. , 1995, Immunity.

[46]  J. Chiche,et al.  Structural and Functional Heterogeneity of Nuclear Bodies , 1999, Molecular and Cellular Biology.